BARCLAYS PLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 109 filers reported holding SEELOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$13,000
-96.7%
15,948
-93.3%
0.00%
Q4 2021$390,000
+302.1%
238,478
+494.0%
0.00%
Q3 2021$97,000
-38.2%
40,146
-32.6%
0.00%
Q2 2021$157,000
+3040.0%
59,608
+5860.8%
0.00%
Q1 2021$5,0001,000
+273.1%
0.00%
Q2 2020$0268
+26700.0%
0.00%
Q4 2019$010.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders